Director of Business Development of Bayshore Specialty Rx’s Shaminder Singh discusses patient support and care delivery, building adaptability and resilience into patient support programs, and the future of healthcare funding in Canada

Head of Canadian Commercial Operations and Strategic Advisor of EMD Serono’s Khalid Sabihuddin discusses translating complex analytics into actionable guidance, international healthcare perspectives, and the healthcare policy climate.

Co-Chairman of BridgeBright Advisors’ Mike Cloutier discusses leadership at scale, leadership in the current political climate, and the hardware for being a successful leader.

Pangaea Consultants’ Managing Director Jeff Martens discusses going from an operating role to consulting, lack of access in today’s political climate, and doing less with more.

Seaford President Tamara Seales discusses navigating Canadian pharma regulations, team-building, and weaving DEI into the fabric of the company.

Mike Exton, CEO and Board Director of Lexicon Pharmaceuticals, talks about safeguards and limits for AI, smaller pharma veresus big pharma, and brand strategies based on data over belief.

Gordon McCauley, CEO of adMare BioInnovations, unpacks the profits, principles, and policies shaping today’s life sci industry.

Casey James Lawton, General Manager at Peirre Fabre Dermo-Cosmetic, talks about diverse career experiences, learning to pivot, and building strong, science-driven foundations.

Fatih Yetikardes, Country Manager of Daiichi Sankyo, gives insights into advancing patient care with company collaborations, the unique complexities of the Canadian healthcare system, and the ethical use and transparent governance of AI.

Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine.